Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ENDO INTERNATIONAL PLC

(ENDP)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/29/2021 07/30/2021 08/02/2021 08/03/2021 08/04/2021 Date
5(c) 5.06(c) 5(c) 4.61(c) 4.65 Last
4 349 129 2 926 450 4 939 340 5 683 872 2 866 798 Volume
-3.66% +1.20% -1.19% -7.80% +0.87% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 2 728 M - -
Net income 2021 122 M - -
Net Debt 2021 6 743 M - -
P/E ratio 2021 4,12x
Yield 2021 -
Sales 2022 2 713 M - -
Net income 2022 216 M - -
Net Debt 2022 6 324 M - -
P/E ratio 2022 3,72x
Yield 2022 -
Capitalization 1 076 M 1 076 M -
EV / Sales 2021 2,87x
EV / Sales 2022 2,73x
Nbr of Employees 3 397
Free-Float 98,5%
More Financials
Company
Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel,... 
Sector
Pharmaceuticals
Calendar
08/05Earnings Release
More about the company
Ratings of Endo International plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about ENDO INTERNATIONAL PLC
11:11aENDO INTERNATIONAL : Settles Opioid Lawsuit in Tennessee for $35 Million - Share..
MT
07:31aENDO INTERNATIONAL : Announces Execution of Definitive Settlement Agreement and ..
PR
07/29ENDO INTERNATIONAL : Presents New Investigational Collagenase Clostridium Histol..
AQ
07/29Endo International plc Presents New Investigational Collagenase Clostridium H..
CI
07/22ENDO INTERNATIONAL : Reaches Agreement in Principle to Settle Opioid-Related Cas..
MT
07/22ENDO INTERNATIONAL : Drugmaker Endo settles opioid claims by Tennessee counties,..
RE
07/22ENDO INTERNATIONAL : Drugmaker Endo settles opioid claims by Tennessee counties,..
RE
07/22ENDO INTERNATIONAL : Announces Agreement in Principle to Settle Tennessee State ..
AQ
07/21FACTBOX-Companies pay billions of dollars over role in U.S. opioid crisis
RE
07/21Drugmakers, pharmacies next targets for U.S. opioid settlements
RE
07/20New York, drug distributors reach $1.18 billion opioid settlement as national..
RE
07/20MARKET CHATTER : Endo Pharmaceuticals Soars After Drug Maker Reportedly Proposes..
MT
07/20SECTOR UPDATE : Health Care Stock Drifting Away From Earlier Highs This Afternoo..
MT
07/20Endo international shares last up 31% at $4.40 in heavy volume
RE
07/15ENDO INTERNATIONAL : Comments on Tennessee Appeals Court Orders
PR
More news
News in other languages on ENDO INTERNATIONAL PLC
07/20Accord à 1,1 milliard de dollars dans la crise des opioïdes à New York
04/20PLANÈTE BOURSEá : La revue de presse du mardi 20 avril 2021
04/20Farmacéuticas acusadas de provocar adicción a opioides van a juicio en Califo..
04/19J&J y otras farmacéuticas serán juzgadas por la epidemia de opiáceos
02/23Farmacéuticas rivales se unen para fabricar más vacunas de Covid-19
More news
Analyst Recommendations on ENDO INTERNATIONAL PLC
More recommendations
Chart ENDO INTERNATIONAL PLC
Duration : Period :
Endo International plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ENDO INTERNATIONAL PLC
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 4,61 $
Average target price 7,63 $
Spread / Average Target 65,4%
EPS Revisions
Managers and Directors
Blaise A Coleman President, Chief Executive Officer & Director
Mark Bradley Chief Financial Officer & Executive Vice President
Mark G. Barberio Chairman
Ruth Thorpe Chief Information Officer
Robert Polke Global Head-Operations